Oncology
Clinical research activity is centered on metastatic breast cancer, with interest in treatment response and disease control in advanced breast malignancy.
- Metastatic breast cancer
- Tumour response assessment
- Clinical benefit
The sponsor’s funded research in this area is directed toward understanding therapeutic activity in patients with advanced disease and evaluating measurable outcomes of anticancer treatment.
Breast Cancer Therapeutics
Its research focus includes interventions for advanced breast cancer, with attention to treatment effects in a setting of progressive and treatment-resistant disease.
- Advanced breast cancer
- Treatment response
- Disease control
This area reflects interest in therapies aimed at improving measurable clinical outcomes for patients with disseminated breast cancer.
Combination Cancer Treatment
The funded trial activity includes evaluation of a combination oncology approach, highlighting interest in therapeutic strategies that pair agents to influence cancer activity.
- Combination therapy
- Anticancer agents
- Therapeutic synergy
Research in this domain is focused on clinical outcomes relevant to the management of metastatic solid tumours.
